Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy

Journal of Urology

Volumn 164, Issue 3 I, 2000, Pages 749-753

  Koch, Michael O ^a   Foster, Richard S ^b   Bell, Bradley ^b   Beck, Stephen ^b   Cheng, Liang ^b   Parekh, Dipen ^b   Jung, Sin Ho ^b  

^a Indiana Cancer Pavilion   (United States)

^b NONE

Author keywords

Prostate; Prostate specific antigen; Prostatic neoplasms; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER RECURRENCE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENT DISEASE;

EID: 0033900078     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)67295-3     Document Type: Article

References (12)

1. Catalona, W. J. and Smith, D. S.: 5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol, 152: 1837, 1994
2. Partin, A. W., Pound, C. R., Clemens, J. Q. et al: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am, 20: 713, 1993
3. Trapasso, J. G., deKernion, J. B., Smith, R. B. et al: The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol, 152:1821, 1994
4. Partin, A. W., Pearson, J. D., Landis, P. K. et al: Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology, 43: 649, 1994
5. Patel, A., Dorey, F., Franklin, J. et al: Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol, 158: 1441, 1997
6. Pound, C. R., Partin, A. W., Eisenberger, M. A. et al: Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281: 1591, 1999
7. Pruthi, R. S., Johnstone, I., Tu, I. P. et al: Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer. Urology, 49: 737, 1997
8. Frazier, H. A., Robertson, J. E., Humphrey, P. A. et al: Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J Urol, 149: 516, 1993
9. Cheng, L., Darson, M. F., Bergstralh, E. J. et al: Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer, 86: 1775, 1999
10. Kattan, M. W., Wheeler, T. M. and Scardino, P. T.: Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol, 17: 1499, 1999
11. Graefen, M., Noldus, J., Pichlmeier, U. et al: Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol, 36: 21, 1999
12. Zincke, H.: Re: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol, 151: 435, 1994